Publications by authors named "Ruth M Starzyk"

Claim this Profile
T
Two-Year outcomes after utilization of the TAXUS paclitaxel-eluting stent in bifurcations and multivessel stenting in the ARRIVE registries.
Emmanouil S Brilakis, John M Lasala, David A Cox, Thomas S Bowman, Ruth M Starzyk

J Interv Cardiol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme.
Michael S Lee, Tae Yang, John M Lasala, David A Cox, Thomas S Bowman, Ruth M Starzyk

EuroIntervention· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program.
Pei-Hsiu Huang, Michael Yeung, John M Lasala, David A Cox, Thomas S Bowman, Ruth M Starzyk

J Interv Cardiol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
Ian T Meredith, Robert Whitbourn, Douglas Scott, Seif El-Jack, Robaayah Zambahari, Ruth M Starzyk

EuroIntervention· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular response to a third generation everolimus-eluting stent.
Gregory J Wilson, Barbara A Huibregtse, Elizabeth A Stejskal, Jody Crary, Ruth M Starzyk

EuroIntervention· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
Emmanouil S Brilakis, John M Lasala, David A Cox, Peter B Berger, Thomas S Bowman, Ruth M Starzyk

JACC Cardiovasc Interv· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
John M Lasala, David A Cox, David Dobies, Kenneth Baran, William B Bachinsky, Ruth M Starzyk

Circ Cardiovasc Interv· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme.
John M Lasala, David A Cox, Stephen J Lewis, Peter N Tadros, Robert C Haas, Ruth M Starzyk

EuroIntervention· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis